What Happened
Pharmaceutical Manufacturing Drives Demand For Specialized Assembly Lines
The European Union market for Industrial Assembly Equipment is driven by the need for pharmaceutical and biopharmaceutical companies to comply with Good Manufacturing Practice (GMP) guidelines. The market is expected to grow at a compound annual growth rate of 4-6% from 2026 to 2035, driven by demand from contract manufacturing organizations (CDMOs) and the need for flexible, multi-format assembly lines. This growth is supported by the increasing demand for biologic drugs, biosimilars, and advanced therapy medicinal products (ATMPs). The market is characterized by high unit values, extended project lifecycles, and deep technical service relationships, according to a report by IndexBox.